T. Kadowaki

发表

Exploratory analysis of biomarkers associated with clinical outcomes from the study of lenvatinib in differentiated cancer of the thyroid.

R. Paschke, M. Schlumberger, S. Sherman, 2017, European journal of cancer.

Gene expression profile in experimental mesangial proliferative glomerulonephritis.

G. Tsujimoto, T. Yukimura, H. Iwao, 2004, Journal of pharmacological sciences.

In silico approach to identify the expression of the undiscovered molecules from microarray public database: identification of odorant receptors expressed in non-olfactory tissues

G. Tsujimoto, A. Ichimura, A. Hirasawa, 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

Structure-activity relationships and pathway analysis of biological degradation processes

M. Kanehisa, S. Goto, M. Hattori, 2006 .

Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis.

G. Tsujimoto, Y. Okuno, S. Katsuma, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma

H. Ueno, K. Okita, M. Ikeda, 2015, Clinical Cancer Research.

Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular

H. Ueno, K. Okita, M. Ikeda, 2015 .

Biological validation that SF3b is a target of the antitumor macrolide pladienolide

Y. Mizui, Y. Kotake, M. Hamaguchi, 2011, The FEBS journal.

Lenvatinib treatment of advanced RAI-refractory differentiated thyroid cancer (DTC): Cytokine and angiogenic factor (CAF) profiling in combination with tumor genetic analysis to identify markers associated with response.

M. Shah, M. Schlumberger, D. Ball, 2012 .

Splice Variant Search with Gene Expression Data

G. Tsujimoto, S. Shiojima, T. Kadowaki, 2003 .

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma

Tim J. Wigle, Yonghong Xiao, R. Copeland, 2014, Molecular Cancer Therapeutics.

Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality

S. Masuda, S. Takekoshi, Y. Tokuda, 2012, British Journal of Cancer.

Mutations of the Gs alpha-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis.

E. Gershon, E. Friedman, P. Gejman, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Mutant Non-Hodgkin Lymphoma EZH 2 Activity in Selective Inhibition of EZH 2 by EPZ-6438 Leads to Potent Antitumor

Yonghong Xiao, R. Copeland, N. Waters, 2014 .

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma

G. Tsujimoto, T. Manabe, O. Ogawa, 2008, Journal of Cancer Research and Clinical Oncology.

Second-line lenvatinib in patients with recurrent endometrial cancer.

I. Vergote, D. Miller, Y. Funahashi, 2020, Gynecologic oncology.

Developmental aberrations of liver gene expression in bovine fetuses derived from somatic cell nuclear transplantation.

G. Tsujimoto, S. Katsuma, Seiya Takahashi, 2006, Cloning and stem cells.

An Ultrasensitive New DNA Microarray Chip Provides Gene Expression Profiles for Preoperative Esophageal Cancer Biopsies without RNA Amplification

G. Tsujimoto, F. Sato, S. Meltzer, 2008, Oncology.

Quantitative phosphorus metabolomics using nanoflow liquid chromatography-tandem mass spectrometry and culture-derived comprehensive global internal standards.

Ken Aoshima, Satoshi Tanaka, Yoshiya Oda, 2009, Analytical chemistry.

Pregnancy-associated changes in genome-wide gene expression profiles in the liver of cow throughout pregnancy.

G. Tsujimoto, S. Katsuma, A. Hirasawa, 2004, Biochemical and biophysical research communications.

Expressions of Cytochrome P450, UDP-Glucuronosyltranferase, and Transporter Genes in Monolayer Carcinoma Cells Change in Subcutaneous Tumors Grown As Xenografts in Immunodeficient Nude Mice

A. Fukamizu, K. Okamoto, T. Kadowaki, 2010, Drug Metabolism and Disposition.

Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation

J. Inazawa, G. Tsujimoto, H. Nishiyama, 2007, British Journal of Cancer.

Analysis of serum biomarkers and tumor genetic alterations from a phase II study of lenvatinib in patients with advanced BRAF wild-type melanoma.

A. Hauschild, K. Flaherty, C. Andresen, 2013 .

Inoculation of Human Tumor Cells Alters the Basal Expression but Not the Inducibility of Cytochrome P450 Enzymes in Tumor-Bearing Mouse Liver

A. Fukamizu, K. Okamoto, T. Kadowaki, 2009, Drug Metabolism and Disposition.

in tumor-bearing mouse liver

A. Fukamizu, K. Okamoto, T. Kadowaki, 2009 .

A phase II trial of lenvatinib in patients with advanced or recurrent endometrial cancer: Angiopoietin-2 as a predictive marker for clinical outcomes.

I. Vergote, T. Pintér, Y. Funahashi, 2013 .

A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction.

Simeon I. Taylor, T. Kadowaki, S. Taylor, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Identification of endocrine disruptor biodegradation by integration of structure-activity relationship with pathway analysis.

M. Kanehisa, Taku Kudo, Hiroshi Mamitsuka, 2007, Environmental science & technology.

Inoculation of Human Tumor Cells Alters the Basal Expression but Not the Inducibility of Cytochrome P450 Enzymes in Tumor-Bearing Mouse Liver

A. Fukamizu, K. Okamoto, T. Kadowaki, 2009, Drug Metabolism and Disposition.

Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma

Yonghong Xiao, R. Copeland, N. Waters, 2014, Molecular Cancer Therapeutics.